52 terminated. 52 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 52 | Terminated 52 |
| Phase 2 | 5 | Terminated 5 |
Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors Best Practice, Entecavir, Tenofovir Alafenamide - Hepatitis B Infection, Malignant Solid Neoplasm | Phase 3 | Terminated | SWOG Cancer Research Network | 4 | 2020-01-17 | 2024-05-20 |
| A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection No Treatment - Hepatitis C | Phase 3 | Terminated | Janssen Research & Development, LLC | 24 | 2017-04-10 | 2025-02-03 |
| Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies LDV/SOF, RBV - Hepatitis C Virus Infection | Phase 3 | Terminated | Gilead Sciences | 87 | 2015-11-11 | 2018-11-16 |
| Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid G-CSF (Filgrastim injection), steroid, placebo - Alcoholic Hepatitis | Phase 3 | Terminated | Chuncheon Sacred Heart Hospital | 64 | 2015-07-01 | 2022-08-08 |
| Primary Prevention Hepatocellular Carcinoma by Metformin Metformin, placebo tablet - Hepatocellular Carcinoma, Hepatitis C, Chronic | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 11 | 2015-06-01 | 2017-01-11 |
| Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV) - Hepatitis C | Phase 3 | Terminated | University of Colorado, Denver | 9 | 2015-05-01 | 2021-09-13 |
| Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection Telbivudine, Placebo - Chronic Hepatitis B | Phase 3 | Terminated | Novartis Pharmaceuticals | 53 | 2014-10-31 | 2019-09-10 |
| To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure ELAD, Standard of Care treatment - Severe Acute Alcoholic Hepatitis | Phase 3 | Terminated | Vital Therapies, Inc. | 18 | 2014-04-01 | 2019-02-19 |
| A Health Intervention to Prevent Depression Hepatitis C Patients Exercise, Health Education - Hepatitis C, Major Depressive Disorder | Phase 2 / Phase 3 | Terminated | University of Texas Southwestern Medical Center | 1 | 2013-06-01 | 2016-12-29 |
| Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) Pegylated Interferon Alfa 2a, Ribavirin, Telaprevir - Infection | Phase 3 | Terminated | M.D. Anderson Cancer Center | 1 | 2013-04-01 | 2020-09-24 |
| Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C Eltrombopag - Thrombocytopenia, Hepatitis C | Phase 2 / Phase 3 | Terminated | University of Texas Southwestern Medical Center | 7 | 2013-04-01 | 2019-11-13 |
| HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin boceprevir, Ribavirin, Peginterferon alfa-2a - Hepatitis C, HIV Infections | Phase 3 | Terminated | Anna Cruceta | 108 | 2013-03-10 | 2025-08-24 |
| A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450) PEG-Intron™, PEGASYS™ - Hepatitis B, Chronic | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 402 | 2012-11-26 | 2018-08-27 |
| 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study Previous treatment in DEB025 study - Hepatitis C, Chronic | Phase 3 | Terminated | Novartis Pharmaceuticals | 105 | 2012-09-06 | 2018-01-12 |
| Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma Tenofovir, Placebo - Chronic Hepatitis B, Hepatocellular Carcinoma | Phase 3 | Terminated | Taichung Veterans General Hospital | 320 | 2012-09-01 | 2014-09-04 |
| Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα Entecavir, Placebo - Chronic Hepatitis B, Rheumatoid Arthritis | Phase 3 | Terminated | Seoul National University Hospital | 43 | 2012-09-01 | 2017-03-06 |
| Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B Entecavir and peginterferon - Hepatitis B | Phase 3 | Terminated | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 28 | 2012-05-01 | 2022-05-26 |
| Long Term Vitamin D Therapy in HCV Treated Patients Vitamin D - Chronic Hepatitis C | Phase 3 | Terminated | Dr. Nadia AbdelAaty AbdelKader | 100 | 2012-04-01 | 2013-11-28 |
| Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C Alisporivir, Peginterferon alfa-2a, Ribavirin - Hepatitis C | Phase 3 | Terminated | Debiopharm International SA | 6 | 2012-03-01 | 2016-08-01 |
| Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1 Alisporivir, Boceprevir, Peginterferon alfa-2a - Hepatitis C | Phase 3 | Terminated | Debiopharm International SA | 8 | 2011-12-01 | 2017-01-16 |
Showing 20 of 52. Sign in to see all of them.
Hepatitis C (19) · Hepatitis C, Chronic (18) · Hepatitis B (15) · Hepatitis B, Chronic (7) · Carcinoma, Hepatocellular (4) · HIV Infections (4) · Acquired Immunodeficiency Syndrome (2) · Hepatitis, Alcoholic (2) · Hepatitis, Chronic (2) · Liver Cirrhosis (2) · Liver Diseases (2) · Thrombocytopenia (2) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1)
Digestive System Diseases (52) · Liver Diseases (50) · Hepatitis, Viral, Human (49) · Virus Diseases (49) · Blood-Borne Infections (48) · Communicable Diseases (48) · Infections (48) · RNA Virus Infections (32) · Flaviviridae Infections (30) · Disease Attributes (28) · Pathologic Processes (28) · Pathological Conditions, Signs and Symptoms (28) · Chronic Disease (27) · Hepatitis, Chronic (25)
Ribavirin (17) · peginterferon alfa-2a (12) · peginterferon alfa-2b (9) · clevudine (6) · Tenofovir (5) · entecavir (4) · N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (3) · Telbivudine (3) · adefovir (3) · telaprevir (3) · alisporivir (2) · eltrombopag (2) · Amantadine (1) · Antiretroviral Therapy, Highly Active (1) · Blood Specimen Collection (1)
Merck Sharp & Dohme LLC (6) · French National Agency for Research on AIDS and Viral Hepatitis (5) · Bukwang Pharmaceutical (3) · GlaxoSmithKline (3) · Novartis Pharmaceuticals (3) · Debiopharm International SA (2) · Novartis (2) · Pharmasset (2) · University Health Network, Toronto (2) · University of Texas Southwestern Medical Center (2) · Vertex Pharmaceuticals Incorporated (2) · Anna Cruceta (1) · Assistance Publique - Hôpitaux de Paris (1) · Bristol-Myers Squibb (1) · Chuncheon Sacred Heart Hospital (1)
United States (19) · Canada (12) · South Korea (9) · France (8) · Spain (8) · Germany (7) · Puerto Rico (6) · Taiwan (6) · Poland (5) · Belgium (4) · Italy (4) · Thailand (4) · United Kingdom (4) · Argentina (3) · Australia (3)
Hyo-Suk Lee, MD. PhD (3) · Alexander Kuo, MD (1) · Amanda Wieland, MD (1) · Amany Y Elkazaz (1) · Andres Duarte-Rojo, MD (1) · Anita Rachlis, MD (1) · Anna Lok, MD (1) · Anne M Larson, MD (1) · Anupama Duddempudi, MD (1) · Averell Sherker, MD (1) · Benoit Trottier, MD (1)
PMID 17593061, PMID 17635375, PMID 17647293, PMID 17850410, PMID 18266997, PMID 19053983, PMID 22913681, PMID 25009371, PMID 25152207, PMID 27219495, PMID 29091342, PMID 30577864, PMID 8213790, PMID 9346731
2008 (2), 2005 (1), 2016 (1), M01RR000040 (1), P30DK050306 (1), U01DK082843 (1), U01DK082863 (1), U01DK082864 (1), U01DK082866 (1), U01DK082867 (1), U01DK082871 (1), U01DK082872 (1), U01DK082874 (1), U01DK082916 (1), U01DK082919 (1)